Skip to main content

Table 2 Primary and secondary outcomes stratified by comorbid HIV

From: Readmission rates in HIV-associated burkitt lymphoma patients in the USA: a nationwide readmission database (NRD) analysis

 

Unadjusted

Adjusted

 

HIV: No

HIV: Yes

Ratio (95% CI)

p

Ratio (95% CI)

p

Index Hospitalization

      

In-patient Mortality (%)

10.83

7.89

0.71 (0.38–1.32)

0.272

0.81 (0.38–1.70)

0.575

Length of Stay (days)

9.23

8.80

0.95 (0.81–1.13)

0.574

1.00 (0.85–1.17)

0.960

Cost ($)

32,735

28,195

0.86 (0.76–0.98)

0.022

0.92 (0.81–1.03)

0.144

All-cause Readmission

      

30-day (%)

67.90

75.42

1.45 (1.06–1.99)

0.021

1.43 (1.04–1.97)

0.026

90-day (%)

75.51

82.42

1.52 (1.04–2.23)

0.031

1.46 (1.00-2.15)

0.053

  1. a. HIV = Human immunodeficiency virus
  2. b. CI = Confidence Interval
  3. c. The NRD sampling design was accounted for in all analyses using SAS v. 9.4 with two-tail p < 0.05 indicating statistical significance